Actinomycin D enhances TRAIL-induced caspase-dependent and -independent apoptosis in SH-SY5Y neuroblastoma cells

Neuroscience Research

Volumn 59, Issue 1, 2007, Pages 40-46

  Wang, Ming Jie ^a   Liu, Shilian ^a   Liu, Yanxin ^a   Zheng, Dexian ^a  

^a INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

Author keywords

Actinomycin D; Apoptosis; Caspases; Neuroblastoma cells; Tumor necrosis factor related apoptosis inducing ligand

Indexed keywords

APOPTOSIS INDUCING FACTOR; BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; CASPASE; CASPASE 3; CASPASE 7; CASPASE 9; DACTINOMYCIN; REACTIVE OXYGEN METABOLITE; RECOMBINANT PROTEIN; RECOMBINANT SOLUBLE TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER RESISTANCE; CELL DEATH; CELL MEMBRANE POTENTIAL; CHEMOSENSITIZATION; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG MECHANISM; DRUG POTENTIATION; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; MITOCHONDRIAL MEMBRANE; NEUROBLASTOMA CELL; PLASMID; PRIORITY JOURNAL; STABLE TRANSFECTION; UPREGULATION;

AMINO ACID CHLOROMETHYL KETONES; APOPTOSIS; CASPASES; CELL LINE, TUMOR; DACTINOMYCIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; ENZYME INHIBITORS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MEMBRANE POTENTIAL, MITOCHONDRIAL; NEUROBLASTOMA; PROTEIN SYNTHESIS INHIBITORS; REACTIVE OXYGEN SPECIES; RECOMBINANT PROTEINS; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TRANSFECTION;

EID: 34548043929     PISSN: 01680102     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neures.2007.05.010     Document Type: Article

References (34)

1. Ashkenazi A., Pai R.C., Fong S., et al. Safety and antitumor activity of recombinant soluble Apo2 ligand. J. Clin. Invest. 104 (1999) 155-162
2. Bian X., Linda, McAllister-Lucas M., et al. NF-κB activation mediates doxorubicin-induced cell death in N-type neuroblastoma cells. J. Biol. Chem. 276 52 (2001) 48921-48929
3. Bidere N., Lorenzo H.K., Carmona S., et al. Cathepsin D triggers Bax activation, resulting in selective apoptosis-inducing factor (AIF) relocation in T lymphocytes entering the early commitment phase to apoptosis. J. Biol. Chem. 278 33 (2003) 31401-31411
4. Bitzer M., Armeanu S., Prinz F., et al. Caspase-8 and Apaf-1-independent caspase-9 activation in sendai virus-infected cells. J. Biol. Chem. 277 33 (2002) 29817-29824
5. Candé C., Cecconi F., Dessen P., et al. Apoptosis-inducing factor (AIF): key to the conserved caspase-independent pathways of cell death?. J. Cell Sci. 115 (2002) 4727-4734
6. Cantarella G., Uberti D., Carsana T., et al. Neutralization of TRAIL death pathway protects human neuronal cell line from beta-amyloid toxicity. Cell Death Differ. 10 1 (2003) 134-141
7. Desagher S., and Martinou J.C. Mitochondrial as the central control point of apoptosis. Trends Cell Biol. 10 (2000) 369-377
8. Eggert A., Grotzer M.A., Zuzak T.J., et al. Resistance to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in neuroblastoma cells correlates with a loss of caspase-8 expression. Cancer Res. 61 4 (2001) 1314-1319
9. Glazyrin A.L., Chinni S., Alhasan S., et al. Molecular mechanism of antnomycin-D induced sensitization of pancreatic cancer cells to CD95 mediated apoptosis. Int. J. Oncol. 20 (2002) 201-205
10. Hadjimitova V., Traykov T., Bakalova R., et al. Chemiluminescent analysis of the antioxidant and immunomodulation effects of several psychotropic drugs on peritoneal macrophages. Luminescence 9 6 (2004) 319-321
11. Harris M.H., and Thompson C.B. The role of the Bcl-2 family in the regulation of outer mitochondrial membrane permeability. Cell Death Differ. 7 12 (2000) 1182-1191
12. Hopkins-Donaldson S., Bodmer J.L., Bourloud K.B., et al. Loss of caspase-8 expression in highly malignant human neuroblastoma cells correlates with resistance to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis. Cancer Res. 60 (2000) 4315-4319
13. Ishii M., Iwai M., Harada Y., et al. Soluble TRAIL gene and actinomycin D synergistically suppressed multiple metastasis of TRAIL-resistant colon cancer in the liver. Cancer Lett. 245 1-2 (2007) 134-143
14. Jo M., Kim T.H., Seol D.W., et al. Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis inducing ligand. Nat. Med. 6 (2000) 564-567
15. Keane M.M., Ettenberg S.A., Nau M.M., et al. Chemotherapy augments TRAIL-induced apoptosis in breast cell lines. Cancer Res. 59 3 (1999) 734-741
16. Lacour S., Hammann A., Wotawa A., et al. Anticancer agents sensitize tumor cells to tumor necrosis factor-related apoptosis-inducing ligand-mediated caspase-8 activation and apoptosis. Cancer Res. 61 4 (2001) 1645-1651
17. Lawrence D., Shahrokh Z., Marsters S., et al. Differential hepatocyte toxicity of recombinant Apo2L/TRAIL versions. Nat. Med. 7 (2001) 383-385
18. Ma A., Cortassa S., Marbán E., et al. Synchronized whole-cell oscillations in mitochondrial metabolism triggered by a local release of reactive oxygen species in cardiac myocytes. J. Biol. Chem. 278 45 (2003) 44735-44744
19. Murahashi H., Azuma H., Zamzami N., et al. Possible contribution of apoptosis-inducing factor (AIF) and reactive oxygen species (ROS) to UVB-induced caspase-independent cell death in the T cell line Jurkat. J. Leukoc. Biol. 73 (2003) 399-406
20. Nesterov A., Ivashchenko Y., and Kraft A.S. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) triggers apoptosis in normal prostate epithelial cells. Oncogene 21 7 (2002) 1135-1140
21. Ng C.P., and Bonavida B. X-linked inhibitor of apoptosis (XIAP) blocks Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis of prostate cancer cells in the presence of mitochondrial activation: sensitization by overexpression of second mitochondria-derived activator of caspase/direct IAP-binding protein with low pI (Smac/DIABLO). Mol. Cancer Ther. 1 (2002) 1051-1058
22. Nitsch R., Bechmann I., Deisz R.A., et al. Human brain-cell death induced by tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). Lancet 356 9232 (2000) 827-828
23. Ohtsuka T., and Zhou T. Bisindolylmaleimide VIII enhances DR5-mediated apoptosis through the MKK4/JNK/p38 kinase and the mitochondrial pathways. J. Biol. Chem. 277 32 (2002) 29294-29303
24. Park Y.W., Ji J.D., Lee J.S., et al. Actinomycin D renders cultured synovial fibroblasts susceptible to tumour necrosis factor related apoptosis-inducing ligand (TRAIL)-induced apoptosis. Scand. J. Rheumatol. 32 6 (2003) 356-363
25. Paul C.P., Good P.D., Winer I., et al. Effective expression of small interfering RNA in human cells. Nat. Biotechnol. 20 (2002) 505-508
26. Petak I., Vernes R., Szucs K.S., et al. A caspase-8-independent component in TRAIL/Apo-2L-induced cell death in human rhabdomyosarcoma cells. Cell Death Differ. 10 6 (2003) 729-739
27. Quirk S.M., Porter D.A., Huber S.C., et al. Potentiation of Fas-mediated apoptosis of murine granulosa cells by interferon-gamma, tumor necrosis factor-alpha, and cycloheximide. Endocrinol. 139 12 (1998) 4860-4869
28. Ravagnan L., Roumier T., and Kroemer G. Mitochondria-the killer organelles and their weapons. J. Cell Physiol. 192 (2002) 131-137
29. Shi J., Liu Y.X., Li X.L., et al. Expression and biological activity of rsTRAIL on killing cancer cells. Chin J. Bioeng. 23 (2003) 46-49
30. Suzuki A., Tsutomi Y., Akahane K., et al. Resistance to Fas-mediated apoptosis: activation of caspase 3 is regulated by cell cycle regulator p21WAF1 and IAP gene family ILP. Oncogene 17 8 (1998) 931-939
31. Wang S., and El-Deiry W.S. TRAIL and apoptosis induction by TNF-family death receptors. Oncogene 22 (2003) 8628-8633
32. Wettsman G.E., Ravid A., Liberman U.A., et al. Vitamin D enhances caspase-dependent and -independent TNFα-induced breast cancer cell death, the role of reactive oxygen species and mitochondria. Int. J. Cancer 10 6 (2003) 178-186
33. Yu R., Mandlekar S., and Kong A.-N.T. Molecular mechanisms of butylated hydroxylanisole-induced toxicity: induction of apoptosis through direct release of cytochrome c. Mol. Pharmacol. 58 2 (2000) 431-437
34. Zangemeister-Wittke U. Antisense to apoptosis inhibitors facilitates chemotherapy and TRAIL-induced death signaling. Ann. N.Y. Acad. Sci. 1002 (2003) 90-94